[HTML][HTML] Humanized mouse models of rheumatoid arthritis for studies on immunopathogenesis and preclinical testing of cell-based therapies

K Schinnerling, C Rosas, L Soto, R Thomas… - Frontiers in …, 2019 - frontiersin.org
Rodent models of rheumatoid arthritis (RA) have been used over decades to study the
immunopathogenesis of the disease and to explore intervention strategies. Nevertheless …

Efficacy of whole cancer stem cell-based vaccines: a systematic review of preclinical and clinical studies

F Hashemi, M Razmi, F Tajik, M Zöller… - Stem Cells, 2023 - academic.oup.com
Background Despite the conventional cancer therapeutic, cancer treatment remains a
medical challenge due to neoplasm metastasis and cancer recurrence; therefore, new …

[HTML][HTML] Proteomes from AMPK-inhibited peripheral blood mononuclear cells suppress the progression of breast cancer and bone metastasis

K Li, X Sun, K Minami, K Tamari, K Ogawa, H Li… - Theranostics, 2023 - ncbi.nlm.nih.gov
Background: During a developmental process, embryos employ varying tactics to remove
unwanted cells. Using a procedure analogous to some of the embryonic cells, we generated …

[HTML][HTML] Counterintuitive production of tumor-suppressive secretomes from Oct4-and c-Myc-overexpressing tumor cells and MSCs

K Li, X Sun, R Zha, S Liu, Y Feng, T Sano, UK Aryal… - Theranostics, 2022 - ncbi.nlm.nih.gov
Background: Advanced breast cancer frequently metastasizes to bone, but inhibiting tumor
progression in chemotherapy may occasionally enhance tumorigenesis. Here, we employed …

Preclinical models and technologies to advance nanovaccine development

C Peres, AI Matos, LIF Moura, RC Acurcio… - Advanced Drug Delivery …, 2021 - Elsevier
The remarkable success of targeted immunotherapies is revolutionizing cancer treatment.
However, tumor heterogeneity and low immunogenicity, in addition to several tumor …

[HTML][HTML] Conversion of osteoclasts into bone-protective, tumor-suppressing cells

KX Li, X Sun, BY Li, H Yokota - Cancers, 2021 - mdpi.com
Simple Summary Osteoclasts are bone-resorbing cells and, together with bone-forming
osteoblasts, they are responsible for maintaining healthy bones. When cancer cells invade …

[HTML][HTML] PI3K-activated MSC proteomes inhibit mammary tumors via Hsp90ab1 and Myh9

X Sun, K Li, UK Aryal, BY Li, H Yokota - Molecular Therapy-Oncolytics, 2022 - cell.com
Despite the advance in medications in the past decade, aggressive breast cancer such as
triple-negative breast cancer is difficult to treat. Here, we examined a counter-intuitive …

Efficacy of an ALDH peptide-based dendritic cell vaccine targeting cancer stem cells

F Liao, J Zhang, Y Hu, AH Najafabadi, JJ Moon… - Cancer Immunology …, 2022 - Springer
Cancer immunotherapies may be limited by their failure to target cancer stem cells (CSCs).
We previously described an approach to target these cells using a dendritic cell (DC) …

Dendritic cells loaded with exosomes derived from cancer stem cell‐enriched spheroids as a potential immunotherapeutic option

M Naseri, M Zöller, J Hadjati, R Ghods… - Journal of Cellular …, 2021 - Wiley Online Library
Cancer stem cells (CSCs) are responsible for therapeutic resistance and recurrence in
colorectal cancer. Despite advances in immunotherapy, the inability to specifically eradicate …

Breast cancer vaccination: Latest advances with an analytical focus on clinical trials

MK Vajari, MJ Sanaei, S Salari, A Rezvani… - International …, 2023 - Elsevier
Breast cancer (BC) is one of the main causes of cancer-related death worldwide. The
heterogenicity of breast tumors and the presence of tumor resistance, metastasis, and …